Abrocitinib may improve itch and quality of life in patients with itch‐dominant atopic dermatitis
Abstract Background Patients with atopic dermatitis (AD) exhibit heterogeneous clinical phenotypes, reflecting different combinations of itch and lesional severity. AD with severe itch but clear‐moderate lesions, also known as itch‐dominant AD, is a common clinical phenotype. Objectives To evaluate...
Saved in:
Main Authors: | Jonathan I. Silverberg (Author), Jacob P. Thyssen (Author), Irina Lazariciu (Author), Daniela E. Myers (Author), Erman Güler (Author), Raj Chovatiya (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Clinical Options for the Management of Itch in Atopic Dermatitis
by: Lipman ZM, et al.
Published: (2021) -
Influence of Itch and Pain on Sleep Quality in Atopic Dermatitis and Psoriasis
by: Karolina Kaaz, et al.
Published: (2018) -
Immune regulation in pathophysiology and targeted therapy for itch in atopic dermatitis
by: Chih-Hung Lee
Published: (2016) -
More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis
by: Andrew Blauvelt, et al.
Published: (2024) -
Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany
by: Elke Weisshaar, et al.
Published: (2023)